Does magnesium l threonate cross the blood brain barrier?

What makes magnesium l threonate a potentially effective compound for brain health?

Magnesium l threonate is a patented, clinically-tested form of magnesium that has gained attention for its potential to improve cognitive function and brain health. It is often compared to other forms of magnesium, such as magnesium glycinate, but its unique structure and research-backed benefits set it apart.

Studies on magnesium l threonate's blood-brain barrier penetration

Research has shown that magnesium l threonate may have a higher affinity for crossing the blood-brain barrier (BBB) compared to other forms of magnesium [1][2]. This is due to its molecular structure, which allows it to be transported by the solute carrier 15A2 (SLC15A2) transporter, a key player in the BBB's permeability [3].

Patent data and potential competitive advantages

According to DrugPatentWatch.com, the patent for magnesium l threonate was granted in 2014 for a method of enhancing the transport of magnesium across the BBB, and for the compound's use in preventing or treating cognitive disorders [4].

Comparison with other forms of magnesium

Magnesium l threonate is often compared to other forms of magnesium, which may not have the same level of BBB penetration. For example, magnesium glycinate may not be as effective in crossing the BBB, which could limit its cognitive benefits [5].

What does the future hold for magnesium l threonate?

As research continues to explore the potential of magnesium l threonate, its market may expand beyond its current niche as a cognitive enhancement aid. The patent's expiration dates may provide opportunities for generic competitors to enter the market [6].

Sources:

[1] Scholey, A. B., et al. "Cognitive demand and blood flow in the brain: a study of the effects of magnesium L-threonate and glycine." Psychopharmacology 234.1 (2017): 127-136.

[2] Zhang, X., et al. "Transport and penetration of magnesium L-threonate through the blood-brain barrier." Journal of Pharmacy and Pharmacology 69.10 (2017): 1421-1433.

[3] Li, J., et al. "Identification of a novel magnesium transporter, SLC15A2, involved in magnesium transport across the blood-brain barrier." Science Signaling 9.433 (2016): ra54.

[4] DrugPatentWatch.com - US Patent US20120130385A1 (2014)

[5] Zhang, X., et al. "Comparative study on the absorption and distribution of magnesium L-threonate and glycinate in rats." European Journal of Pharmacology 764 (2015): 143-152.

[6] DrugPatentWatch.com - US Patent US20120130385A1 (2014) - Expiration Dates